Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R U Müller

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
ZFA. Zeitschrift Fur Allgemeinmedizin|May 10, 1976
[Child health care]R U Müller
Deutsche Medizinische Wochenschrift (1946)|February 9, 2011
[Treating the symptoms in nephrotic syndrome: which therapeutic strategies are evidence based in the treatment of proteinuria?]T Kisner, R-U Müller, T Benzing
Oncogene|May 8, 2009
The mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cellsM Kato, T Paranjape, R U Müller, et al.
Scientific Reports|August 29, 2023
The effect of mycophenolate mofetil on podocytes in nephrotoxic serum nephritisA Hackl, E Nüsken, J Voggel, et al.
BMC Gastroenterology|February 26, 2022
Protocol for a randomized controlled multicenter trial assessing the efficacy of leuprorelin for severe polycystic liver disease: the AGAINST-PLD studyS E Aapkes, L H P Bernts, A P van den Berg, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
ZFA. Zeitschrift Fur Allgemeinmedizin|May 10, 1976
[Child health care]R U Müller
Deutsche Medizinische Wochenschrift (1946)|February 9, 2011
[Treating the symptoms in nephrotic syndrome: which therapeutic strategies are evidence based in the treatment of proteinuria?]T Kisner, R-U Müller, T Benzing
Oncogene|May 8, 2009
The mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cellsM Kato, T Paranjape, R U Müller, et al.
Scientific Reports|August 29, 2023
The effect of mycophenolate mofetil on podocytes in nephrotoxic serum nephritisA Hackl, E Nüsken, J Voggel, et al.
BMC Gastroenterology|February 26, 2022
Protocol for a randomized controlled multicenter trial assessing the efficacy of leuprorelin for severe polycystic liver disease: the AGAINST-PLD studyS E Aapkes, L H P Bernts, A P van den Berg, et al.
Pageof 1